Zurich, Zurich, Switzerland
• Strategic, entrepreneurial, both individual and team oriented professional • Commercial operations analytics, market research, forecasting, sales force effectiveness and CRM, business development, strategic counselling and presentations to senior management • Experience with multiple product and indication launches • Agile, able to cope with ambiguity
Part of the Global Strategy team (USA) but based in Switzerland. - Corporate Development / Strategy / Transformation - M&A due diligence and CI / industry trends - Management reporting / BoD
Specialist consulting firm | ex-US business strategy for clinical stage assets | biotech business launch • Supported clients in collaboration with LivBio in evaluating commercial expansion plans for US-EU product launches in various therapeutic areas • Designed and conducted market research with actionable insights that provided strategic directions to commercial expansion decisions • Provided analogues for product launches, companies expansions case studies • Supported the headcount planning, resource allocation plans, timelines for beach-head EU strategy • Provided business analytics intelligence supporting US commercial team in assessing products and pipeline potential in EU-JP-UK-Nordics
Global Market Analytics and Business Intelligence Lead for RINVOQ UC • Core member of the Rinvoq Global brand team (GBT) providing guidance, acting as the voice of customer and providing strategic input to the Brand plan and and GBT topics • Designed and conducted market research with actionable insights that impacted the business • Tracked the performance of Rinvoq UC as product launches, conducted analyses at patient level to share data globally, diagnosed enablers and barriers to product launch • Identified gaps in the research objectives and developed budget for following years • Served as an active contributor in meetings, providing strategic directions citing data to clarify questions
Responsible for Ex-US commercial/marketing market research, insights, analytics and forecasting (reporting to commercial head) • US centralized and local Market research for Etrasimod and pipeline assets • Commercial footprint planning for new affiliates in EU • Epidemiology-based forecasting and price-volume analyses based on potential EU labels • Coordination with US team for ad-hoc insights/analytics projects
Responsible for the International Markets commercial/marketing analytics (reporting to commercial head) • Forecasting and insights for pipeline products (Reblozyl®, Inrebic®, Ozanimod®, CAR-T) • Commercial assessment of new markets and launch opportunities • KPIs creation, tracking and alignment headquarters-affiliates • Strategic analytical support for regional prioritization • Market access analytics